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Recommended for incoming undergraduate students, the book provides a quick
understanding ofthe important terms and techniques forcurrentDNA-relatedresearch. Its
utility for medical students, however, is somewhat limited by its brevity and enormous
scope. At almost $40 in hardcover, the book is far too expensive. At $16.95 in softcover,
it remains somewhat less so, but may be worth the cost for a rapid introduction to genet-
ic engineering.
Jersey Chen
Medical Student
Yale University School ofMedicine
ADVERSE EVENTS ASSOCIATED WITH CHILDHOOD VACCINES: EVIDENCE
BEARING ON CAUSALITY. Edited by Kathleen R. Stratton, Cynthia J. Howe and
Richard B. Johnson, Jr. Washington, D.C., NationalAcademy Press, 1993. 464 pp. $49.95.
This report, prepared by the Vaccine Safety Committee, Division of Health
Promotion and Disease Prevention, Institute of Medicine, is a careful and exhaustive
review ofevidence from the scientific literature and from adverse event surveillance sys-
tems, concerning causal relationships, or lack thereof, between each adverse experience
(AE) and the vaccine that preceded it. It supplements a companion volume (Adverse
Effects ofPertussis and Rubella Vaccines) and addresses AE issues related to diphtheria
and tetanus (T) toxoids (or DT for children and Td for adults if combined), measles,
mumps, polio (OPV and IPV), hepatitis B and Hemophilus influenzae type b vaccines.
Evidence on causality of AEs is categorized into five classes, including: no evidence,
inadequate evidence, evidence favoring rejection, evidence favoring acceptance or evi-
dence establishing a causal relationship with the given vaccine. Special analyses are
included ofthe evidentiary basis for causality, ofthe varieties ofneurologic and immuno-
logic reactions and of post-vaccination death. The last chapter reviews areas most need-
ing additional research and enhanced surveillance.
Most ofthe serious AEs reviewed are rare, a fact that poses some difficulty in assess-
ing causality, since rare serious AEs are typically far less often reported after vaccination
compared to the population at large. Additional difficulty arises from the paucity ofcon-
trolled trial data, a deficiency often impossible to remedy, given the huge populations
needed to ensure detection of such rare events. The majority of the data, based on case
reports and uncontrolled observational studies, is therefore appropriately graded as inde-
terminate by the committee. The rarity of the most serious AEs, especially compared to
adverse outcomes caused by the respective diseases prevented by vaccination, points to
the immense societal benefit in relation to the rare risk of serious harm associated with
mass vaccination with these vaccines.
Key findings include evidence favoring rejection of causal linkage between
encephalopathy, sudden infant death syndrome (SIDS) or infantile spasms and DT or Td
(or T separately) and between early onset H. influenzae b disease and related conjugate
vaccines. Evidence wasjudged to favor acceptance ofcausality between DT, Td or T and
brachial neuritis or Guillain-Barre syndrome, between measles vaccine and anaphylactic
reactions, between OPV and Guillain-Barre and between early onset H. influenzae b dis-
ease in children under 18 months old and previous vaccination with unconjugated PRP
vaccine. Causality established by the evidence was determined foranaphylaxis following
DT, Td or T; thrombocytopenia, anaphylaxis or measles virus-related death (in the
immunocompromised) after measles vaccination; recipient or contact polio or related
death after OPV; and anaphylaxis after hepatitis B vaccination.BookReviews
This book is a useful comprehensive compendium, which helps to focus on what is
known and what is unknown about vaccine safety and on how to prioritize future research
efforts in this area. As furtherresearch elucidates the incidence ofother non-vaccine related
(but potentially concurrent) causes for some of these rare AEs (e.g., Guillain-Barre syn-
drome caused by Campylobacterjejuni infection, as yet unknown specific causes of SIDS
or deaths due to child abuse masquerading as SIDS) specific diagnostic, clinical and epi-
demiologic methods will become applicable with which vaccine causality can better be dif-
ferentiated from random background events. While anaphylax is will always bepossible, its
rarity and the paucity offatal anaphylaxis reports is encouraging and is presumably a trib-
ute to appropriate therapeutic intervention. The trend in evolution ofnew vaccines ofgreat-
ly enhanced purity and single-dose immunogenicity should also help reduce vaccine-relat-
edAEs. In an era offrequently exaggerated, erroneous, and inappropriate media attention to
alleged vaccine-related AEs rather than benefit-to-risk comparisons, this book provides a
carefully balanced assessment of medicine's most useful and beneficial tools and offers a
powerful reference and a blueprint for further such assessments.
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